Aviva PLC (AV)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 715.80 |
|---|---|
| 52-week range | 590.60 – 740.60 |
| Return, 1 month / 3 months | +1.4% / +6.1% |
| Return, 1 year / 3 years | +14.6% / +120.5% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 20.5% |
| Worst drawdown (1 year) | -11.9% |
| Average daily value traded | 4,979.25M GBX |
| Dividend yield | 5.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aviva is an insurance and financial services company based in London. It provides life insurance, general insurance, pensions and savings products to individuals and businesses, and it also manages investments through its asset management arm. Its customers include households and companies, and it serves markets in the United Kingdom, Ireland, Canada and elsewhere. The company combines protection, retirement and investment offerings under the Aviva brand.
Aviva PLC trades under the code AV on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aviva PLC (AV) trades on the London Exchange in UK. It last closed at GBX 715.80 on 22 October 2026.
Its price-based Market X-Ray is 81 out of 100 (a strong price profile), ranking 34 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.6% and over the last three months it rose 6.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 82 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.4% | ||
| From 52-week high | -2.9% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.1% | ||
| 6-month return | 14.3% | ||
| 12-month return, skipping the last month | 13.1% | ||
| Stability (higher is calmer) | 89 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.9% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 4,979.25M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | +1.4% |
| 3 months | +6.1% |
| 6 months | +14.3% |
| 1 year | +14.6% |
| 3 years | +120.5% |
| 5 years | +92.8% |
Signals
| 50-day / 200-day average | 704.95 / 642.81 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.79 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Sep 2026 | GBP 0.1400 |
| 26 Mar 2026 | GBP 0.2620 |
| 28 Aug 2025 | GBP 0.1310 |
| 10 Apr 2025 | GBP 0.2380 |
| 5 Sep 2024 | GBP 0.1190 |
| 11 Apr 2024 | GBP 0.2230 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.